0001567619-20-001131.txt : 20200116
0001567619-20-001131.hdr.sgml : 20200116
20200116121309
ACCESSION NUMBER: 0001567619-20-001131
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200116
DATE AS OF CHANGE: 20200116
EFFECTIVENESS DATE: 20200116
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aligos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001799448
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-358226
FILM NUMBER: 20530066
BUSINESS ADDRESS:
STREET 1: ONE CORPORATE DR., 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (800) 466-6059
MAIL ADDRESS:
STREET 1: ONE CORPORATE DR., 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
D
1
primary_doc.xml
X0708
D
LIVE
0001799448
Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
(800) 466-6059
DELAWARE
Aligos, Inc.
None
Corporation
true
2018
Lawrence
Blatt
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Chief Executive Officer
Leonid
Beigelman
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
President
Lucinda
Quan
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Executive Vice President - General Counsel
Brian
Dowd
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Executive Vice President - Controller
John
Fry
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Executive Vice President - Clinical Development
Julian
Symons
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Executive Vice President - Chief Scientific Officer
Sushmita
Chanda
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Executive Vice President - Preclinical Development
Peter
Moldt
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Jack
Nielsen
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Carole
Neuchterlein
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Peter
Hirth
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Tom
Woiwode
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Kathleen
Glaub
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Michael
Yi
c/o Aligos Therapeutics, Inc.
One Corporate Dr., 2nd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Biotechnology
Decline to Disclose
- 06b
false
2019-12-23
false
true
false
0
125000167
85000001
40000166
false
38
0
0
0
false
Aligos Therapeutics, Inc.
/s/ Lawrence Blatt
Lawrence Blatt
Chief Executive Officer
2020-01-09